References
Legislation
UK
- Health and Social Care Act, (2012). https://www.legislation.gov.uk/ukpga/2012/7/section/75/enacted
- Procurement Bill [HL], Grand Committee, (26 October 2022). https://bills.parliament.uk/publications/48269/documents/2396
- The Public Contracts Regulations, Statutory Instrument n.102, (2015). https://www.legislation.gov.uk/uksi/2015/102/mad
- The National Health Service (Procurement, Patient Choice and Competition) (No. 2) Regulations, Statutory Instrument 500, (2013). https://www.legislation.gov.uk/uksi/2013/500/made
- Health and Care Act, (2022). https://www.legislation.gov.uk/ukpga/2022/31/enacted
- Retained EU Law (Revocation and Reform) Bill (2022). https://bills.parliament.uk/bills/3340/publications
EU
- Directive 2014/24/EU of the European Parliament and of the Council of 26 February 2014 on public procurement and repealing Directive 2004/18/EC Text with EEA relevance. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32014L0024
- Directive 93/42/EEC of 14 June 1993 concerning medical devices. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2016.119.01.0001.01.ENG&toc=OJ%3AL%3A2016%3A119%3ATOC
- Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A31998L0079
- Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32011L0062
- Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20170505
- Regulation (EU) 2017.746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices. https://eur-lex.europa.eu/eli/reg/2017/746/oj
- Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2016.119.01.0001.01.ENG&toc=OJ%3AL%3A2016%3A119%3ATOC
- Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A31989L0105
- Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross border healthcare. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:088:0045:0065:en:PDF
- European Union (Eur-Lex, 2021) Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R2282
Literature
- Armstrong, K. A. (2018). Regulatory alignment and divergence after Brexit. Journal of European Public Policy, 25(8), 1099–1117. https://doi.org/10.1080/13501763.2018.1467956
- Armstrong, K. A. (2020). Regulatory autonomy after EU membership: Alignment, Divergence and the Discipline of Law. European Law Review, 45(2), 207–221. https://doi.org/10.2139/ssrn.3593482
- Association of British HealthTech Industries. (2021). How realistic is the 1st July 2023 deadline? https://www.abhi.org.uk/membership/members-area/monthly-reports-spotlights/2021/october/how-realistic-is-the-1st-july-2023-deadline/
- Baldwin, R., Cave, M., & Lodge, M. (2010). Introduction: Regulation, the field and the developing agenda. In R. Baldwin, M. Cave, & M. Lodge (Eds.), The Oxford handbook on regulation (pp. 3–16). Oxford University Press.
- Baldwin, R., Cave, M., & Lodge, M. (2012). Understanding regulation: Theory, strategy, and practice (2nd edn.). Oxford University Press.
- Black, J. (2002). Critical reflections on regulation. Australian Journal of Legal Philosophy, 27, 1–35.
- Börzel, T. A., & Risse, T. (2012). From Europeanisation to diffusion: Introduction. West European Politics, 35(1), 1–19. https://doi.org/10.4324/9781003061373
- Bradford, A. (2012). The Brussels effect. Northwestern University Law Review, 107(1), 1–67.
- Cabinet Office. (2020). Transforming Public Procurement. Government Publishing Service. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/943946/Transforming_public_procurement.pdf
- Cabinet Office (UK Government. (2022). The benefits of Brexit. https://www.gov.uk/government/publications/the-benefits-of-brexit
- Cary, W. L. (1974). Federalism and Corporate Law: Reflections upon Delaware. The Yale Law Journal, 83(4), 663–705. https://doi.org/10.2307/795524
- Chief Scientific Advisor. (2023). Letter from Sir Patrick Vallance to the Chancellor. HM Treasury. https://www.gov.uk/government/publications/pro-innovation-regulation-of-technologies-review-life-sciences-interim-report/letter-from-sir-patrick-vallance-to-the-chancellor#:~:text = Pro%2DInnovation%20Regulation%20of%20Technologies%20Review,-I%20recently%20wrote&text = The%20MHRA%20is%20recognised%20as,the%20UK%20system%20can%20act
- Collins, B. (2015). Procurement and competition rules: Can the NHS be exempted? King’s Fund. https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/procurement-competition-rules-kings-fund-mar-2015.pdf
- Competition and Markets Authority. (2021). Transforming Public Procurement: Response from the Competition and Markets Authority. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/974861/CMA_Response_to_Transforming_Public_Procurement_Green_Paper_.pdf
- Cygan, A. (2020). De-Europeanisation of UK regulatory governance and the future UK-EU trade relationship. ERA Forum 20, 509–529. https://doi.org/10.1007/s12027-020-00599-6
- Dayan, M., Hervey, T., Flear, M., Jarman, H., McCarey, M., Fahy, N., & Greer, S. L. (2022). Protocol politics mean hard times ahead for health in Northern Ireland. Nuffield Trust. https://www.nuffieldtrust.org.uk/news-item/protocol-politics-mean-hard-times-ahead-for-health-in-northern-ireland
- Dayan, M., McCarey, M., Hervey, T., Fahy, N., Greer, S. L., Jarman, H., Stewart, E., & Bristow, D. (2021). Going it alone: Health and Brexit in the UK. Nuffield Trust. https://www.nuffieldtrust.org.uk/research/going-it-alone-health-and-brexit-in-the-uk.
- De Maria, C., Di Pietro, L., Díaz Lantada, A., Madete, J., Ngaju Makobore, P., Mridha, M., Ravizza, A., Torop, J., & Ahluwalia, A. (2018). Safe innovation: On medical device legislation in Europe and Africa. Health Policy and Technology, 7(2), 156–165. https://doi.org/10.1016/j.hlpt.2018.01.012
- Dennis, A. (2022). Analysis: MHRA response to consultation on UK regulation of medical devices. Taylor Wessing. https://www.taylorwessing.com/en/insights-and-events/insights/2022/08/mhra-response-to-consultation-on-uk-regulation-of-medical-devices
- Diamond, P. (2020). Polycentric governance and policy advice: Lessons from Whitehall policy advisory systems. Politics & Policy, 48. https://doi.org/10.1332/030557320X15870482509817
- Diamond, P. (2021). Cummings’s evidence reinforces the impression that ineptitude over COVID-19 reflected errors made by individual ministers. That’s only part of the story. LSE Politics & Policy Blog. https://blogs.lse.ac.uk/politicsandpolicy/covid19-cummings-public-administration/
- Dobson, S.-J. (2021). The legislation and regulation of medical devices. In P. Feldschreiber (Ed.), The law and regulation of medicines and medical devices. Oxford University Press. https://doi.org/10.1093/oso/9780192847546.003.0007
- Eisner, M. A. (2017). Regulatory politics in an age of polarization and drift: Beyond deregulation. Routledge.
- Esping-Andersen, G. (1999). Social foundations of postindustrial economies. Oxford University Press.
- European Commission. (2021a). Data protection: Commission adopts adequacy decisions for the UK. European Commission. https://ec.europa.eu/commission/presscorner/detail/en/ip_21_3183
- European Commission. (2021b). Regulatory framework proposal on artificial intelligence. European Commission. https://digital-strategy.ec.europa.eu/en/policies/regulatory-framework-ai
- European Commission. (2021c). Horizon Europe: The EU research and innovation programme. Publications Office of the European Union. https://op.europa.eu/en/web/eu-law-and-publications/publication-detail/-/publication/93de16a0-821d-11eb-9ac9-01aa75ed71a1
- European Commission. (2022). Proposal for a Regulation of the European Parliament and of the Council on the European Health Data Space. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri = celex%3A52022PC0197
- European Commission. (2023). Proposal for a regulation of the European Parliament and of the Council on specific rules relating to medicinal products for human use intended to be placed on the market of Northern Ireland. https://commission.europa.eu/system/files/2023-02/COM_2023_122_1_EN_ACT_part1_v2.pdf
- European Medicines Agency. (2020). Authorisation of medicines. https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines
- European Medicines Agency. (2022a). Clinical Trials Regulation. https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials/clinical-trials-regulation
- European Medicines Agency. (2022b). PRIME: Priority Medicines. https://www.ema.europa.eu/en/human-regulatory/research-development/prime-priority-medicines
- European Union. (2014). Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A32014R0536
- Fahy, N., Hervey N., Dayan, M., Flear, M., Galsworthy, M., Greer, S., Jarman, H., & McKee, M. (2020). Assessing the potential impact on health of the UK's future relationship agreement with the EU: Analysis of the negotiating positions. Health Economics, Policy and Law, 16(3), 290–307. http://doi.org/10.1017/S1744133120000171
- Falkner, R., & Gupta, A. (2009). The limits of regulatory convergence: Globalization and GMO politics in the south. Int Environ Agreements, 9, 113–133. https://doi.org/10.1007/S10784-009-9094-X
- Hacker, J. S. (2004). Privatizing risk without privatizing the welfare state: The hidden politics of social policy retrenchment in the United States. American Political Science Review, 98(2), 243–260. https://doi.org/10.1017/S0003055404001121
- Hansard. (2021). Department for Business Written Questions: House of Commons 1st March 2021.
- Hansard. (2022). Procurement Bill: House of Lords Volume 825, Monday 28th November 2022.
- Health and Social Care Committee. (2018). Brexit: Medicines, medical devices, and substances of human origin. House of Commons.
- Her Majesty’s Treasury. (2018). EU Exit Long-term economic analysis. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/760484/28_November_EU_Exit_-_Long-term_economic_analysis__1_.pdf
- Her Majesty’s Treasury. (2023). Spring Budget 2023. https://www.gov.uk/government/publications/spring-budget-2023/spring-budget-2023-html
- Hoey, R. (2007). Lancet. The EU Clinical Trials Directive: 3 years on thelancet.com/journals/lancet/article/PIIS0140-6736(07)60797-1/fulltext
- Jancic, D. (2022). Regulatory strings that bind and the UK Parliament after Brexit. Comp Eur Polit, 20, 566–584. https://doi.org/10.1057/s41295-022-00296-3
- Kassim, H., Davis, C., Ennis, S., & Jordan, A. (2021). UK Regulation after Brexit. UK in a Changing Europe.
- Kassim, H., Davis, C., Ennis, S., & Jordan, A. (2022). UK Regulation after Brexit revisited. UK in a Changing Europe.
- Laurie, G. (2018). How do we make sense of chaos? Navigating health research regulation through the liminality of the Brexit process. Medical Law International, 18(2–3), 110–134. https://journals.sagepub.com/doi/full/10.11770968533218799533#fn72-0968533218799533
- Lavenex, S., & Schimmelfennig, F. (2009). EU rules beyond EU borders: Theorizing external governance in European politics. Journal of European Public Policy, 16(6), 791–812. https://doi.org/10.1080/13501760903087696
- Levi-Faur, D. (2014). The odyssey of the regulatory state: From a ‘thin’ monomorphic concept to a ‘thick’ and polymorphic concept. Law and Policy, 35. https://doi.org/10.1111/lapo.12000
- Majone, G. (1997). From the positive to the regulatory state. Journal of Public Policy, 17(2). https://doi.org/10.1017/S0143814X00003524
- Majone, G. (2004). Regulating Europe. Routledge.
- McCarey, M., Dayan, M., Hervey, T., Flear, M., Jarman, H., Fahy, N., Greer, S. L., & Bristow, D. (2022). Brexit: Six years on. Nuffield Trust. https://www.nuffieldtrust.org.uk/research/health-and-brexit-six-years-on
- MedTech Europe. (2022). MedTech Europe Survey Report analysing the availability of Medical Devices in 2022 in connection to the Medical Device Regulation (MDR) implementation. MedTech Europe. https://www.medtecheurope.org/wp-content/uploads/2022/07/medtech-europe-survey-report-analysing-the-availability-of-medical-devices-in-2022-in-connection-to-the-medical-device-regulation-mdr-implementation.pdf
- MHRA. (2020). Regulatory approval of Pfizer/BioNTech vaccine for Covid-19. MHRA. https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19
- MHRA. (2022a). Government response to consultation on the future regulation of medical devices in the United Kingdom. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1085333/Government_response_to_consultation_on_the_future_regulation_of_medical_devices_in_the_United_Kingdom.pdf
- MHRA. (2022b). First bivalent covid-19 booster vaccine approved by UK medicines regulator. MHRA. https://www.gov.uk/government/news/first-bivalent-covid-19-booster-vaccine-approved-by-uk-medicines-regulator
- MHRA. (2023). Government response to consultation on legislative proposals for clinical trials. MHRA. https://www.gov.uk/government/consultations/consultation-on-proposals-for-legislative-changes-for-clinical-trials/outcome/government-response-to-consultation-on-legislative-proposals-for-clinical-trials
- Murray, C. R. G., & Robb, N. (2023). From the Protocol to the Windsor Framework. Northern Ireland Legal Quarterly.
- National Audit Office. (2020). The supply of personal protective equipment during the Covid-19 Pandemic. NAO. https://www.nao.org.uk/reports/supplying-the-nhs-and-adult-social-care-sector-with-personal-protective-equipment-ppe/
- OECD. (2012). Fighting Bid-Rigging in Public Procurement. https://www.oecd.org/competition/cartels/fightingbidrigginginpublicprocurement.htm
- Parker, G. (2022). UK plan to scrap all EU laws suffers new setback. Financial Times. https://www.ft.com/content/0c0593a3-19f1-45fe-aad1-2ed25e30b5f8
- Parker, G., Staton, B., & Bounds, A. (2023). Rishi Sunak holds back on rejoining Horizon after Brexit breakthrough. Financial Times. https://www.ft.com/content/409bccc7-8cb4-4f44-87c4-340d15147c55
- Phillips, A. (2021). Boris Johnson: 30 medicines unavailable in NI due to EU protocol. Chemist & Druggist. https://www.chemistanddruggist.co.uk/CD007244/Boris-Johnson-30-medicines-unavailable-in-NI-due-to-EU-protocol
- Prange-Gstöhl, H. (2009). Enlarging the EU’s internal energy market: Why would third countries accept EU rule export? Energy Policy, 37(12), 5296–5303. https://doi.org/10.1016/J.ENPOL.2009.07.070
- Prime Minister’s Office. (2022). Prime Minister pledges Brexit Freedoms Bill to cut red tape. Number 10 Downing Street. https://www.gov.uk/government/news/prime-minister-pledges-brexit-freedoms-bill-to-cut-eu-red-tape
- Schon, D. A., & Rein, M. (1995). Frame reflection: Towards the resolution of intractable policy controversies. Little, Brown.
- Shleifer, A. (2005). Understanding regulation. European Financial Management, 11(4), 439–451. https://scholar.harvard.edu/files/shleifer/files/02_eufm00121.pdf
- Streeck, W., & Thelen, K. (2005). Beyond continuity: Institutional change in advanced political economies. Oxford University Press.
- Sunak, R. (2022). We got Brexit done – now we must capitalise on the freedoms it gave us. Daily Telegraph.
- Taskforce for Innovation. Growth and Regulatory Reform (UK Government, 2022). Final Report https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/994125/FINAL_TIGRR_REPORT__1_.pdf
- Thompson, B. (2022). Horizon Europe unites scientists – let’s keep it separate from debates over the Northern Ireland protocol. Wellcome Trust. https://wellcome.org/news/horizon-europe-unites-scientists-northern-ireland-protocol-debates
- Transparency International. (2021). Concern over corruption red flags in 20% of UK PPE procurement. https://www.transparency.org.uk/track-and-trace-uk-PPE-procurement-corruption-risk-VIP-lane
- UK Government. (2020a). UK-EU Trade and Cooperation Agreement Summary. Government Publishing Service. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/962125/TCA_SUMMARY_PDF_V1-.pdf
- UK Government. (2020b). Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community. National Archives. https://www.legislation.gov.uk/eut/withdrawal-agreement/contents/adopted
- UK Government. (2023). The Windsor Framework: A new way forward. HM Stationery Office. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1138989/The_Windsor_Framework_a_new_way_forward.pdf
- UK Parliament. (2022). Written Question and Answer 63308. https://questions-statements.parliament.uk/written-questions/detail/2022-10-14/63308
- UKRI. (2022). Horizon Europe funding: Help for UK applicants. UKRI. https://www.ukri.org/apply-for-funding/horizon-europe/
- Vahl, M., & Grolimund, N. (2006). Integration without membership: Switzerland’s bilateral agreements with the European union. Centre for European Policy Studies.
- Van Arnum, P. (2020). The UK and the Pharma Industry in a post-Brexit world. DCAT VCI. https://www.dcatvci.org/features/uk-and-pharma-in-a-post-brexit-world/
- Van Ramsdonk, A., & Hill, K. (2022). What will the new UK MHRA consultation mean in terms of medical device and IVD regulations? Emergo. https://www.emergobyul.com/blog/2022/07/what-will-uk-mhra-consultation-bring-terms-medical-device-and-ivd-regulations
- Vaughan, R. (2023). Windsor Framework NI protocol deal ‘immediately’ paves way for UK to rejoin £84bn Horizon Europe scheme. The Independent. https://inews.co.uk/news/politics/windsor-framework-ni-protocol-deal-immediately-paves-way-uk-rejoin-eu-84bn-horizon-research-scheme-2176626
- Vidigal, G. (2018). From the board: The nativist turn one year on: Is the system holding? Legal Issues of Economic Integration, 45(2), 111–119. https://doi.org/10.54648/leie2018006
- Vote Leave. (2016). Briefing: Leave is the best choice for science and technology. http://www.voteleavetakecontrol.org/briefing_science.html
- Young, A. R. (2015). The European Union as a global regulator? Context and comparison. Journal of European Public Policy, 22(9), 1233–1252. https://doi.org/10.1080/13501763.2015.1046902